BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Breast cancer AND HSP90AB1, HSPCB, 3326, ENSG00000096384, HSP90B, HSP90-BETA, P08238, D6S182, HSPC2, FLJ26984 AND Treatment
11 results:

  • 1. Identification of Hub Genes and Upstream Regulatory Factors Based on Cell Adhesion in Triple-negative breast cancer by Integrated Bioinformatical Analysis.
    Han YH; Wang Y; Lee SJ; Mao YY; Jiang P; Sun HN; Jin MH; Kwon T
    Anticancer Res; 2023 Jul; 43(7):2951-2964. PubMed ID: 37351977
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Counterintuitive production of tumor-suppressive secretomes from Oct4- and c-Myc-overexpressing tumor cells and MSCs.
    Li K; Sun X; Zha R; Liu S; Feng Y; Sano T; Aryal UK; Sudo A; Li BY; Yokota H
    Theranostics; 2022; 12(7):3084-3103. PubMed ID: 35547745
    [No Abstract]    [Full Text] [Related]  

  • 3. Suppression of breast cancer-associated bone loss with osteoblast proteomes via hsp90ab1/moesin-mediated inhibition of TGFβ/FN1/CD44 signaling.
    Sun X; Li K; Hase M; Zha R; Feng Y; Li BY; Yokota H
    Theranostics; 2022; 12(2):929-943. PubMed ID: 34976221
    [No Abstract]    [Full Text] [Related]  

  • 4. Long non-coding RNA NKILA regulates expression of HSP90α, NF-κB and β-catenin proteins in the MCF-7 breast cancer cell line.
    Tibatan MA; Önay Uçar E
    Mol Biol Rep; 2021 May; 48(5):4563-4571. PubMed ID: 34125329
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Transcriptomic insights into the zinc homeostasis of MCF-7 breast cancer cells via next-generation RNA sequencing.
    Zaman MS; Barman SK; Corley SM; Wilkins MR; Malladi CS; Wu MJ
    Metallomics; 2021 Jun; 13(6):. PubMed ID: 33960390
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. EEF1A2 interacts with hsp90ab1 to promote lung adenocarcinoma metastasis via enhancing TGF-β/SMAD signalling.
    Jia L; Ge X; Du C; Chen L; Zhou Y; Xiong W; Xiang J; Li G; Xiao G; Fang L; Li Z
    Br J Cancer; 2021 Mar; 124(7):1301-1311. PubMed ID: 33473168
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Heat Shock Protein 90 Family Isoforms as Prognostic Biomarkers and Their Correlations with Immune Infiltration in breast cancer.
    Lin T; Qiu Y; Peng W; Peng L
    Biomed Res Int; 2020; 2020():2148253. PubMed ID: 33145341
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. USP22-dependent hsp90ab1 expression promotes resistance to HSP90 inhibition in mammary and colorectal cancer.
    Kosinsky RL; Helms M; Zerche M; Wohn L; Dyas A; Prokakis E; Kazerouni ZB; Bedi U; Wegwitz F; Johnsen SA
    Cell Death Dis; 2019 Dec; 10(12):911. PubMed ID: 31801945
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Proteogenomic integration reveals therapeutic targets in breast cancer xenografts.
    Huang KL; Li S; Mertins P; Cao S; Gunawardena HP; Ruggles KV; Mani DR; Clauser KR; Tanioka M; Usary J; Kavuri SM; Xie L; Yoon C; Qiao JW; Wrobel J; Wyczalkowski MA; Erdmann-Gilmore P; Snider JE; Hoog J; Singh P; Niu B; Guo Z; Sun SQ; Sanati S; Kawaler E; Wang X; Scott A; Ye K; McLellan MD; Wendl MC; Malovannaya A; Held JM; Gillette MA; Fenyö D; Kinsinger CR; Mesri M; Rodriguez H; Davies SR; Perou CM; Ma C; Reid Townsend R; Chen X; Carr SA; Ellis MJ; Ding L
    Nat Commun; 2017 Mar; 8():14864. PubMed ID: 28348404
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Ratio of proliferation markers and HSP90 gene expression as a predictor of pathological complete response in breast cancer neoadjuvant chemotherapy.
    Jarzab M; Kowal M; Bal W; Oczko-Wojciechowska M; Rembak-Szynkiewicz J; Kowalska M; Stobiecka E; Chmielik E; Tyszkiewicz T; Kaszuba M; Nowicka E; Lange B; Czarniecka A; Krajewska J; Dyla A; Dobrut M; Lange D; Jarzab B; Bobek-Billewicz B; Tarnawski R
    Folia Histochem Cytobiol; 2016; 54(4):202-209. PubMed ID: 28051275
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Amplification and high-level expression of heat shock protein 90 marks aggressive phenotypes of human epidermal growth factor receptor 2 negative breast cancer.
    Cheng Q; Chang JT; Geradts J; Neckers LM; Haystead T; Spector NL; Lyerly HK
    Breast Cancer Res; 2012 Apr; 14(2):R62. PubMed ID: 22510516
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.